PAM
ALPN

Panagora Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Panagora Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,394
Closed -$127K – 1324
2023
Q2 		$127K Buy
+12,394
New +$112K ﹤0.01% 1221
2019
Q3 		– Sell
-6,042
Closed -$25K – 2669
2019
Q2 		$25K Sell
6,042
-261
-4% -$1.51K ﹤0.01% 2235
2019
Q1 		$43K Sell
6,303
-438
-6% -$2.73K ﹤0.01% 2077
2018
Q4 		$25K Sell
6,741
-127
-2% -$626 ﹤0.01% 2168
2018
Q3 		$43K Sell
6,868
-2,395
-26% -$16.8K ﹤0.01% 2050
2018
Q2 		$70K Buy
9,263
+1,400
+18% +$11.5K ﹤0.01% 1963
2018
Q1 		$63K Hold
7,863
– – ﹤0.01% 1969
2017
Q4 		$88K Buy
+7,863
New +$85.6K ﹤0.01% 1912
2017
Q2 		– Sell
-36,762
Closed -$429K – 2671
2017
Q1 		$429K Sell
36,762
-24,645
-40% -$250K ﹤0.01% 1411
2016
Q4 		$550K Buy
+61,407
New +$1.22M ﹤0.01% 1407
2015
Q4 		– Sell
-8,861
Closed -$460K – 2379
2015
Q3 		$460K Buy
+8,861
New +$582K ﹤0.01% 1342

Other funds holding ALPN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Panagora Asset Management's ALPN Position: Q3 2023 in Review

Panagora Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2023, closing a stake of 12,394 shares — an estimated $127K sold.

Panagora Asset Management first reported a position in ALPN in Q3 2015 and held it in 11 quarters. The position peaked at $550K in Q4 2016. 88 funds tracked by Wall St. Rank hold ALPN as of Q3 2023.

  • Panagora Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q3 2023 after selling out during the quarter.
  • Panagora Asset Management sold 12,394 Alpine Immune Sciences Inc shares in Q3 2023, an estimated $127K.
  • Panagora Asset Management first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 11 quarters.
  • Panagora Asset Management's Alpine Immune Sciences Inc position peaked at $550K in Q4 2016.
  • 88 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2023.

Based on Panagora Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.